Cited by 974Telomeres, Telomerase, and SenescenceGenetics, Aging, and Longevity in Model OrganismsT-cell and B-cell Immunology

An aged immune system drives senescence and ageing of solid organs

Open access
Yousefzadeh, Matthew J., Flores, Rafael R., Zhu, Yi, Schmiechen, Zoe C., Brooks, Robert W., Trussoni, Christy E., Cui, Yuxiang, Angelini, Luise +25 more·2021·Nature

Abstract

Ageing of the immune system, or immunosenescence, contributes to the morbidity and mortality of the elderly 1,2. To define the contribution of immune system ageing to organism ageing, here we selectively deleted Ercc1, which encodes a crucial DNA repair protein 3,4, in mouse haematopoietic cells to increase the burden of endogenous DNA damage and thereby senescence 5-7 in the immune system only. We show that Vav-iCre+/-;Ercc1-/fl mice were healthy into adulthood, then displayed premature onset of immunosenescence characterized by attrition and senescence of specific immune cell populations and impaired immune function, similar to changes that occur during ageing in wild-type mice 8-10. Notably, non-lymphoid organs also showed increased senescence and damage, which suggests that senescent, aged immune cells can promote systemic ageing. The transplantation of splenocytes from Vav-iCre+/-;Ercc1-/fl or aged wild-type mice into young mice induced senescence in trans, whereas the transplantation of young immune cells attenuated senescence. The treatment of Vav-iCre+/-;Ercc1-/fl mice with rapamycin reduced markers of senescence in immune cells and improved immune function 11,12. These data demonstrate that an aged, senescent immune system has a causal role in driving systemic ageing and therefore represents a key therapeutic target to extend healthy ageing.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/s41586-021-03547-7

Cites

41 of 41 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Once the senescent cell burden passes a threshold, further increases in proapoptotic/pro-inflammatory senescent cells may cause tissue destruction, disease progression, immune dysregulation, and a feed-forward loop of accumulation.

    “Once senescent cell burden surpasses this threshold, continuing increases in proapoptotic/pro-inflammatory senescent cell burden may contribute to tissue destruction and hence development or progression of multiple diseases and age-related disorders (Table 2) as well as immune dysregulation, further amplifying senescent cell accumulation in a feed-forward loop36,38,62.”

    From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [38]

    The Abstract describes senescent cells as pro-inflammatory and tissue damaging and links them to age-related diseases. The “Rapamycin rejuvenates immune cells” section reports that immune-cell senescence impairs immunity and drives senescence in solid organs. Neither passage establishes a burden threshold, describes these cells as proapoptotic, or identifies the claimed feed-forward loop of accumulation; page numbers are not available in our copy. (LLM, conf=0.87)

    Experimental — accuracy not yet measured
  • Senescent cell fate can be triggered by many stressors, including DNA damage, oncogene activation, mitochondrial dysfunction, reactive metabolites, oxygen extremes, proteotoxic stress, extracellular signals, infections, mechanical or shear stress, resistance exercise, and factors secreted by other senescent cells.

    “The senescent cell fate can be triggered by a number of stressors including DNA damage, cancerous mutations or oncogene activation, mitochondrial dysfunction, reactive metabolites, hyperoxia or hypoxia, proteotoxic stress, extracellular signals, infections, mechanical or shear stresses that deform cells, resistance exercise and factors secreted by other senescent cells18,38–47.”

    From Cellular senescence and senolytics: the path to the clinic (2022) · cites this paper as [38]

    The Abstract (page unavailable) says stress can activate senescence, and the Rapamycin rejuvenates immune cells section specifically links unrepaired endogenous DNA damage to immune-cell senescence. The Cell autonomous mechanism section also suggests aged splenocytes can drive senescence in other tissues. The paper does not establish the rest of the listed triggers, including oxygen extremes, mechanical stress and resistance exercise. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • Mouse models of rapid telomere shortening, dysfunctional mitosis, or impaired DNA repair (Terc, BubR1, and Ercc1 mutant mice, respectively) display high levels of cellular senescence and accelerated aging.

    “Mouse models of rapid telomere shortening, dysfunctional mitosis or impaired DNA repair (Terc, BubR1, and Ercc1 mutant mice, respectively), display high levels of cellular senescence and accelerated aging86,99,100.”

    From Guidelines for minimal information on cellular senescence experimentation in vivo (2024) · cites this paper as [99]

    The Abstract (page not provided) says that reduced ERCC1–XPF impairs DNA repair, increases senescent cells in mouse tissues, and accelerates ageing. The paper’s passages do not address Terc or BubR1 mutant mice, so it supports only the Ercc1 portion of the claim. (LLM, conf=0.88)

    Experimental — accuracy not yet measured
  • CD3+ T cells from aged mice and ERCC1-deficient mice show increased levels of Ccl2, Tnf, Il1b, Inhba, Spp1, Cdkn2a, and Cdkn1a.

    “CD3+ T cells isolated from the blood of aged mice and of mice deficient in ERCC1, which is a crucial DNA repair protein, exhibit increased levels of multiple senescent markers, including Ccl2, Tnf, Il1b, Inhba, Spp1, Cdkn2a and Cdkn1a (refs. 85,86).”

    From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [86]

    The Immune cell senescence section reports increased senescence and SASP markers in peripheral CD3+ cells from aged ERCC1-deficient mice, analogous to aged wild-type mice. It identifies p16 (Cdkn2a), p21 (Cdkn1a), Ccl2, Tnf and Il1b among the markers studied, but does not establish that every listed gene increased in blood CD3+ cells in both groups. Searches for Inhba and Spp1 found no supporting passage. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Pathological aging of organs increases the level of inflammation and makes repair difficult, ultimately leading to diseases.

    “As a result of the effects of cellular senescence, chronic inflammation, and immunosenescence, the pathological aging of organs increases the level of inflammation and makes repair difficult, ultimately leading to diseases.10”

    From Inflammation and aging: signaling pathways and intervention therapies (2023) · cites this paper as [10]

    The Tissue damage section (page unavailable) reports increased inflammatory factors and impaired muscle regeneration in mice with an aged immune system. The paper links senescent immune cells to damage and age-related changes in solid organs, but it does not establish the claim’s sequence that pathological organ ageing itself increases inflammation, impedes repair generally, and ultimately causes disease. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

2 of the 43 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Yousefzadeh, M. J., Flores, R. R., Zhu, Y., Schmiechen, Z. C., Brooks, R. W., Trussoni, C. E., Cui, Y., Angelini, L., Lee, K.-A., McGowan, S. J., Burrack, A. L., Wang, D., Dong, Q., Lu, A., Sano, T., O’Kelly, R. D., McGuckian, C. A., Kato, J. I., Bank, M. P., Wade, E. A., Pillai, S. P. S., Klug, J., Ladiges, W. C., Burd, C. E., Lewis, S. E., LaRusso, N. F., Vo, N. V., Wang, Y., Kelley, E. E., Huard, J., Stromnes, I. M., Robbins, P. D., & Niedernhofer, L. J.
Affiliations
  • University of Minnesota (US)
  • Mayo Clinic (US)
  • Scripps Research Institute (US)
  • University of California, Riverside (US)
  • University of Pittsburgh (US)
  • The University of Texas Health Science Center at Houston (US)
  • Fred Hutch Cancer Center (US)
  • University of Washington (US)
  • The Ohio State University (US)
  • West Virginia University (US)
Corresponding author
  • Robbins, Paul D.
  • Niedernhofer, Laura J.
Venue
Nature
Published
2021-05-12
Volume
594
Issue
7861
Pages
100-105
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W3161778279
Cited by
972
References
43
Citations by year
2026: 176 · 2025: 219 · 2024: 219 · 2023: 186 · 2022: 131 · 2021: 41
FWCI
91.03
Type
journal article
Language
en
Open access
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Funders
  • National Institute on Aging (P01AG043376, R01AG059711, R01AG067193, R01AG044376, R56AG059676, R56AG058543, T32AG029796, U19AG056278, P01AG062413, R01AG063543)
  • National Cancer Institute (R01CA249393, R01CA255039)
  • National Institute of Diabetes and Digestive and Kidney Diseases (P30DK084567)
Topics
  • Health Sciences › Medicine › Physiology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
Keywords
immunosenescence, cellular senescence, ERCC1, DNA repair, endogenous DNA damage, hematopoietic cells, rapamycin, senolytics, healthy aging
MeSH terms
Immunosenescence, Healthy Aging, Aging, Animals, DNA Damage, DNA Repair, DNA-Binding Proteins, Endonucleases, Female, Homeostasis, Immune System, Male, Organ Specificity, Rejuvenation, Spleen, Sirolimus, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review